Dr Austin Smith

Austin Smith is a Medical Director at Valo Therapeutics Oy with a decade of experience in oncolytic virus development, spanning programme design, clinical execution, and regulatory strategy. Dually trained in medical oncology and pharmaceutical medicine, he has led interactions with the FDA, EMA, and MHRA across multiple modalities. He brings deep translational and clinical expertise to oncolytic virus programmes in solid tumour indications.